Axitinib Metabolite B |
|
| Synonyms: Axitinib Sulfoxide ;(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylsulfinyl)benzamide;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]-benzamide;Axitinib Impurity 5 | |
| Cat. No.: A86031 | CAS No.: 1347304-18-0 |
| MDL.: | Formula: C22H18N4O2S |
| F.W.402.47 | Purity: 99％ |
| Storage: 4°C | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 5mg | $205.00 | Enter qty and click checkbox |
 
|
$205.00 |
| Catalog Number： | A86031 | CAS No.: | 1347304-18-0 | |
| MDL: | Formula: | C22H18N4O2S | ||
| F.W.: | 402.47 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | Light Yellow Solid | M.P.: | >225 (dec.) | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO (Slightly), Methanol (Slightly, Heated) | Stability: | ||
| Storage: | 4°C | Category: | Reference Standard | |
| Reference: | Wasser, K., et al.: Eur. Radiol., 13, 80 (2003), Park, J., et al.: Clin. Cancer Res., 8, 1172 (2002), Bergers, G., et al.: J. Clin. Invest., 111, 1287 (2003), | |||
| Application: | Axitinib Sulfoxide is a major metabolite of Axitinib, a tyrosine kinase inhibitor. Axitinib is used in cancer therapy. | |||
| Category: | Aromatics, Metabolites, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, | |||